Max Healthcare Institute has announced strong financial results for the September quarter. The company’s net profit surged by 74% year-on-year to Rs 491 crore. Revenue from operations also saw a significant increase of 25% to Rs 2,135 crore. This performance reflects robust growth driven by factors like increased occupied bed days and international patient revenue.
Tata Sons boardroom battle intensifies but Tata Group stocks remain unbothered. Should you buy?
Tata Sons has rejected Noel Tata’s objections to N Chandrasekaran’s reappointment, saying the board’s decision was valid and made in accordance with the company’s Articles